机译:通过抑制TGF-B1途径治疗特发性肺纤维化药物候选物的合成和发现(Vol 157,PG 229,2018)
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Chinese Peoples Armed Police Forces Logist Univ Pingjin Hosp Dept Resp &
Crit Care Med Tianjin;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Chinese Peoples Armed Police Forces Logist Univ Pingjin Hosp Dept Resp &
Crit Care Med Tianjin;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
Nankai Univ Tianjin Key Lab Mol Drug Res State Key Lab Med Chem Biol Coll Pharm Tianjin 300350;
机译:通过抑制TGF-B1途径治疗特发性肺纤维化药物候选物的合成和发现(Vol 157,PG 229,2018)
机译:S1P2拮抗剂GLPG2938的发现(1- [2-乙氧基-6-(三氟甲基)-4-吡啶基] -3 - [[5-甲基-6- [1-甲基-3-(三氟甲基)吡唑-4- y1 ]吡啶汀-3-基]甲基]尿素),一种治疗特发性肺纤维化的临床前候选者
机译:2(1H)-Qquinolone衍生物的设计,合成和发现用于治疗TGF-β/ Smad依赖性和独立途径的抑制作用肺纤维化
机译:特发性肺纤维化:发病机制,进展,治疗和未来前景
机译:基于转录组的候选性肺纤维化治疗疗法
机译:S1P2拮抗剂GLPG2938的发现(1- 2-乙氧基-6-(三氟甲基)-4-吡啶基 -3 - 5-甲基-6- 1-甲基-3-(三氟甲基)吡唑-4- y1吡啶嗪-3-基甲基尿素)治疗特发性肺纤维化的临床前候选者